RS
Ranjna Singh
About Ranjna Singh
Data last updated:
Ranjna Singh is a Director at Netmusk Energies Private Limited (since 2025) and Director at Ariso Pharma Private Limited (since 2024). The companies operate in Home Appliances. Earlier, Ranjna Singh was a Director at Rlc Cure Private Limited (2022–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Nov 2025 | 2025 | Active | ||
| Director | 22 Jan 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 May 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ranjna Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Badal Kumar Saxena | 08244170 | Netmusk Energies Private Limited | Director |
| Vaibhava Krishna | 11375163 | Netmusk Energies Private Limited | Director |
| Sushil Singh | 10475875 | Ariso Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ranjna Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ranjna Singh
Ranjna Singh currently holds 2 directorships: Netmusk Energies Private Limited (Director, since 10 Nov 2025); Ariso Pharma Private Limited (Director, since 22 Jan 2024).
Ranjna Singh was first appointed on 23 May 2022 as Director at Rlc Cure Private Limited. The most recent appointment on record is 10 Nov 2025 at Netmusk Energies Private Limited.
Ranjna Singh held 1 earlier board appointment: Rlc Cure Private Limited (Director, 23 May 2022 to 06 Jan 2023).
The current boards of Ranjna Singh's companies include Badal Kumar Saxena (Netmusk Energies Private Limited), Vaibhava Krishna (Netmusk Energies Private Limited), Sushil Singh (Ariso Pharma Private Limited).